Urotensin II and Biomarkers of Endothelial Activation and Atherosclerosis in End-Stage Renal Disease

The inverse links between UTN with biomarkers of atherosclerosis and endothelial activation suggest that downregulation of UTN may be a counter-regulatory response aimed at mitigating cardiovascular damage or that UTN itself is a protective factor.